@nirav_maine @HHSGov @BARDA And 8) while not as far along and as straightforward, mRNA vaccine could also be helpful in other diseases like cancer!
English
Jens Rueter
40 posts
Jens Rueter
@RueterJens
Chief Medical Officer at The Jackson Laboratory, Medical Director for the Maine Cancer Genomics Initiative, community oncologist in rural Maine
参加日 Ağustos 2021
38 フォロー中41 フォロワー
1/The recent move by @HHSGov and @BARDA to wind down mRNA vaccine development is a setback for public health preparedness.
Bottom line: it leaves us less safe and secure, not more.
hhs.gov/press-room/hhs…
English
Great honor to have @Dr_R_Kurzrock, a true pioneer in Precision Oncology, at our 2024 MCGI Forum. @jax_mcgi @JAXcancercenter @jacksonlab
Razelle Kurzrock, MD@Dr_R_Kurzrock
Honor to give the Keynote for the MCGI Forum, and to meet Jens Reuter, the CMO for The Jackson Laboratory Amazing meeting and dinner too!!
English
Jens Rueter がリツイート
Honor to give the Keynote for the MCGI Forum, and to meet Jens Reuter, the CMO for The Jackson Laboratory
Amazing meeting and dinner too!!
English
Jens Rueter がリツイート
Congratulations @MeghnaTrivedi3 @RueterJens @Amich1122 @DrDawnHershman et al for their Featured Abstract @ #ASCOQLTY23: "Mixed-methods analysis of physician genomic confidence in ... cluster randomized trial evaluating genomic tumor boards (@SWOG S2108CD)" ascopubs.org/doi/10.1200/OP…
English
Jens Rueter がリツイート
🚨🚨Exciting news! Hot off the press with a simultaneous publication in @AACR Cancer Discovery @CD_AACR with the @ASCO #ASCO23 clinical science symposium meeting 👉🏼 So honored to present to the world 👉🏼RLY-4008 - the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations & resistance mutations.
🔺Promising results in FGFR2-positive cholangiocarcinoma & other advanced solid tumors @OncoAlert @ElizSMcKenna @AliSchram @OncBrothers #PrecisionMedicine for the win 🎯🧬
aacrjournals.org/cancerdiscover…
English
Universal germline testing in all cancer patients would certainly change current practice. While thought-provoking and intriguing, this will also require novel approaches in care delivery, including education of clinicians and patients. @jax_mcgi @JAXClinicalEd @JAXcancercenter
Ed Esplin, MD, PhD@EdEsplin
UPDATE: #Germlinetesting is standard of care for #breastcancer, #coloncancer, #ovariancancer, #prostatecancer, & #PancreaticCancer #Universal #germlinetesting needed to win the war against #cancer @VivekSubbiah @Dr_R_Kurzrock @JCO_ASCO ascopubs.org/doi/full/10.12… "We are going to be incorporating #germlinetesting in most if not all of our #patients w/ #cancer...& we've got to be prepared for that" - #DrRenatoMartins @VCUMassey @ASCO #ASCO23 #access #reducedisparities #genetictesting #precisionmedicine #precisiontherapy #clinicaltrials #precisionprevention
English
Jens Rueter がリツイート
Finally, some good news for patients with IDH mutant glioma!! Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma nejm.org/doi/full/10.10…
English
When not at @ASCO 2023…not so bad reading about the presentations in front of a nice wood stove fire on this uncharacteristically cool June day in Maine…
English
Precision oncology, one step at a time…@SWOG
SWOG Cancer Research Network@SWOG
Dr. @NaglaAKarimMD presents results of @SWOG S1929 at #ASCO23: Adding a PARP inhibitor (talazoparib) to checkpoint blockade significantly extended PFS for patients w extensive-stage small-cell #lungcancer whose tumors express SLFN11. Biomarker selected treatment in #SCLC #LCSM
English
Another important finding supporting rational drug choices. @jax_mcgi
JCO Precision Oncology@JCOPO_ASCO
.@KariWisinski_MD et al report on results from #NCI-MATCH trial where trametinib didn't meet its objective response rate goal in NF1, GNAQ or GNA11 altered tumors but some stable diseases observed suggest need to explore further in certain disease types: fal.cn/3yaUV
English
REALLY excited for this @SWOG S2108CD trial using #genomictumortesting to inform treatment options for any solid tumor #cancerpatients w/ #metastatic or #recurrentdisease. Find out more below! #CancerTwitter #OncTwitter #swogonc #clinicalstudies
swog.org/clinical-trial…
English
On the heels of this publication, it’s great to be at the Spring 2023 @SWOG meeting and run into @ARosen380 and listen to @MeghnaTrivedi3’s great talk at the Translational Medicine Plenary, mentioning our S2108CD cluster-randomized trial investigating genomic tumor boards
Jens Rueter@RueterJens
Very happy to share our experience in implementing a rural community precision oncology program in Maine. #PrecisionMedicine @jacksonlab @jax_mcgi @JAXClinicalEd @JAX_CKB @NorthernLightH @MaineHealth ascopubs.org/doi/10.1200/PO…
English
Very happy to share our experience in implementing a rural community precision oncology program in Maine. #PrecisionMedicine @jacksonlab @jax_mcgi @JAXClinicalEd @JAX_CKB @NorthernLightH @MaineHealth ascopubs.org/doi/10.1200/PO…
English
Jens Rueter がリツイート
Biomedical researchers and clinical experts are giving guest lectures about cancer biology, the unique features of cancer genomes, bioinformatic approaches used in #CancerResearch and more.
Yesterday, Dr. Jens Rueter (@RueterJens) discussed human subjects research and @JAX_MCGI!
English
Congrats to @ProfDMThomas and team. Important findings regarding the attitudes of cancer patients towards their own genetic and genomic findings
Professor DM Thomas@ProfDMThomas
94% of individuals affected by cancer want to know genetic results which are preventable or treatable. 60% want to know, even if there are no treatments. @OmicoAustralia @UNSWMedicine #RisC study. sciencedirect.com/science/articl…
English
Jens Rueter がリツイート
.@HemOncToday interviews @MeghnaTrivedi3 and @RueterJens on @SWOG S2108CD #clinicaltrial:
Trial to investigate impact of genomic tumor board on physician, patient outcomes healio.com/news/hematolog…
English